Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
02 December 2024
| Name: | CHEMGENEX PHARMACEUTICALS LTD (CXS) | ||||||||||||||||||
| Date of Listing: | 10 July 1986 | ||||||||||||||||||
| Date of Delisting: | 22 July 2011 | ||||||||||||||||||
| Former Names: |
|
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 22 July 2011.Legal Status:
To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.Capital Gains Tax (CGT) Status:
To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| Company | FROM | TO |
|---|---|---|
| CHEMGENEX PHARMACEUTICALS LTD | 29/06/2004 | |
| AGT BIOSCIENCES LIMITED | 24/03/2003 | 29/06/2004 |
| AUTOGEN LIMITED | 14/05/1999 | 24/03/2003 |
| AUSTRALIA WIDE INDUSTRIES LIMITED | 05/06/1986 | 14/05/1999 |
| KINGSWAY GROUP LIMITED | 01/08/1964 | 05/06/1986 |
| N AND B FINANCE AND DEVELOPMENT CORPORATION LIMITED | 01/08/1964 |
REGISTRY:
Link Market Services Brisbane
Level 21, 10 Eagle Street
Brisbane QLD 4000
Tel : +61 7 3320 2200 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail
many shareholders in this company have unclaimed money due to them - deListed provides a tracing service for a small administration fee that identifies where people can find unclaimed monies arising from compulsory acquisitions and also from dividend distributions, super contributions, inoperative bank, building society or credit union accounts, bequests and other sources - please click here for access to our Lost shares, Lost money?? service | 31/03/2022 |
delisted following completion of the takeover offer made by Cephalon Inc. | 22/07/2011 |
we understand Cephalon was successful with off-market takeover offer of $0.70 cash per share and $0.02 cash per listed option | 22/07/2011 |
Cephalon CXS Holdings Ltd bought 9,113,676 ChemGenex Pharmaceuticals Ltd shares between July 12 and 15, 2011 via takeover offer, increasing from 304,445,194 shares (97.09%) to 313,558,870 shares (100%) | 21/07/2011 |
Cephalon CXS Holdings Ltd bought 12,198,508 ChemGenex Pharmaceuticals Ltd shares between June 15 and July 9, 2011 via takeover offer, increasing from 292,246,686 shares (93.20%) to 304,445,194 shares (97.09%) | 12/07/2011 |
the securities of ChemGenex Pharmaceuticals Limited (the "Company") will be suspended from quotation at the close of trading on Tuesday, 21 June 2011 in accordance with listing rule 17.4, following the issue by Cephalon Inc. of compulsory acquisition notices | 21/06/2011 |
shares reinstated to quotation | 09/04/2009 |
the securities of ChemGenex Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company | 08/04/2009 |
we understand that on or about this date the company made an in specie distribution of 1 share in Autogen Research Pty Ltd for every 5 shares in the company | 17/12/2007 |
we understand that on or about this date the company demerged Autogen (subsequently renamed Verva Pharmaceuticals Ltd) | 15/11/2007 |
shares reinstated to quotation following receipt of an announcement providing details of the Company's completed capital raising | 08/05/2006 |
advises of the intended offer of 35m ordinary shares by placement to selected sophisticated or professional investors | 04/05/2006 |
securities suspended from quotation at the request of the company pending the release of an announcement | 03/05/2006 |
name changed from AGT Biosciences Limited | 29/06/2004 |
many shareholders in this company have unclaimed money due to them - deListed provides a tracing service for a small administration fee that identifies where people can find unclaimed monies arising from compulsory acquisitions and also from dividend distributions, super contributions, inoperative bank, building society or credit union accounts, bequests and other sources - please click here for access to our Lost shares, Lost money?? service | 31/03/2022 |
delisted following completion of the takeover offer made by Cephalon Inc. | 22/07/2011 |
we understand Cephalon was successful with off-market takeover offer of $0.70 cash per share and $0.02 cash per listed option | 22/07/2011 |
Cephalon CXS Holdings Ltd bought 9,113,676 ChemGenex Pharmaceuticals Ltd shares between July 12 and 15, 2011 via takeover offer, increasing from 304,445,194 shares (97.09%) to 313,558,870 shares (100%) | 21/07/2011 |
Cephalon CXS Holdings Ltd bought 12,198,508 ChemGenex Pharmaceuticals Ltd shares between June 15 and July 9, 2011 via takeover offer, increasing from 292,246,686 shares (93.20%) to 304,445,194 shares (97.09%) | 12/07/2011 |
the securities of ChemGenex Pharmaceuticals Limited (the "Company") will be suspended from quotation at the close of trading on Tuesday, 21 June 2011 in accordance with listing rule 17.4, following the issue by Cephalon Inc. of compulsory acquisition notices | 21/06/2011 |
shares reinstated to quotation | 09/04/2009 |
the securities of ChemGenex Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company | 08/04/2009 |
we understand that on or about this date the company made an in specie distribution of 1 share in Autogen Research Pty Ltd for every 5 shares in the company | 17/12/2007 |
we understand that on or about this date the company demerged Autogen (subsequently renamed Verva Pharmaceuticals Ltd) | 15/11/2007 |
shares reinstated to quotation following receipt of an announcement providing details of the Company's completed capital raising | 08/05/2006 |
advises of the intended offer of 35m ordinary shares by placement to selected sophisticated or professional investors | 04/05/2006 |
securities suspended from quotation at the request of the company pending the release of an announcement | 03/05/2006 |
name changed from AGT Biosciences Limited | 29/06/2004 |
Your browser may reflect a date of printing in American format.
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| James Campbell | CFO, COO | |
| Kevin Buchi | Director | |
| Ron Kal | Director, Company Secretary | |
| Wilco Groenhuysen | Director | |
| Tony Johnson | Director |
Date of first appointment, title may have changed.
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
